Margaret Tempero, MD
Professor
Medicine
School of Medicine

415-353-7528

Margaret Tempero, MD, is a Professor of Medicine and Director of the UCSF Pancreas Center and editor-in-chief of JNCCN. Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board.

Show full bio (170 words) Hide full bio

She codirected the AACR/ASCO Methods in Clinical Cancer Research and taught this course and similar courses in Europe and Australia. She was founding Chair of the NCI Clinical Oncology Study Section and served as a member and Chair of the NCI Board of Scientific Counselors Subcommittee A. She is a member of the Scientific Steering Committee and Chair of the Clinical and Translational Study Section for the Cancer Prevention & Research Institute of Texas. She is or has been on the Scientific Advisory Boards of the Lustgarten Foundation, the Pancreatic Cancer Action Network, the V Foundation, The Alberta Canada Cancer Board, and the EORTC. She served as a member of the Oncology Drug Advisory Committee for the FDA. She has served as Deputy Director and Interim Director for the UNMC Eppley Cancer Center. She is Chief Emeritus of the Division of Medical Oncology at UCSF. She served as the founding Deputy Director and was later Director of Research Programs at the UCSF Helen Diller Family Comprehensive Cancer Center.

Awards

Show all (3) Hide

  • Editor-In-Chief, Journal Nat'l Comprehensive Cancer Network, 2014-Pres
  • Rombauer Family Distinguished Professorship in Pancreas Cancer Clinical and Translational Science, UCSF, 2012-Pres
  • Doris and Don Fisher Distinguished Professor in Clinical Research, UCSF, 2000-2012

Education & Training

Show all (1) Hide

  • M.D. School of Medicine University of Nebraska 1977

Interests

Show all (13) Hide

  • Cancer
  • biomarkers
  • quality of life
  • antibodies
  • clinical trials
  • radioimmunoconjugate
  • gastrointestinal cancers
  • gemcitabine
  • practice guidelines
  • pancreatic adenocarcinoma
  • immunotherapy
  • CA 19-9
  • pancreas

Websites

Show all (2) Hide

Grants and Projects

Show all (6) Hide

Publications (279)

Top publication keywords:
Patient CareMedical OncologyAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsNeoplasmsHealth Care CostsOncologistsCarcinoma, Pancreatic DuctalAdenocarcinomaDeoxycytidineDrug ApprovalAntimetabolites, AntineoplasticPancreatic NeoplasmsReimbursement MechanismsCA-19-9 Antigen

Show all (274 more) Hide